How many Aurinia Pharmaceuticals shares are in issue?
Aurinia Pharmaceuticals has 143,833,000 shares in issue.
What is the market cap of Aurinia Pharmaceuticals?
The market capitalisation of Aurinia Pharmaceuticals is CAD 1.12 B.
What is the 1 year trading range for Aurinia Pharmaceuticals share price?
Aurinia Pharmaceuticals has traded in the range of $ 7.80 to $ 7.80 during the past year.
What is the PE ratio of Aurinia Pharmaceuticals?
The price to earnings ratio of Aurinia Pharmaceuticals is -16.45.
What is the cash to sales ratio of Aurinia Pharmaceuticals?
The cash to sales ratio of Aurinia Pharmaceuticals is 7.31.
What is the reporting currency for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals reports financial results in USD.
What is the latest annual turnover for Aurinia Pharmaceuticals?
The latest annual turnover of Aurinia Pharmaceuticals is USD 175.51M.
What is the latest annual profit for Aurinia Pharmaceuticals?
The latest annual profit of Aurinia Pharmaceuticals is USD -78.02M.
What is the registered address of Aurinia Pharmaceuticals?
The registered address for Aurinia Pharmaceuticals is 1203-4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8.
What is the Aurinia Pharmaceuticals website address?
The website address for Aurinia Pharmaceuticals is www.auriniapharma.com.
Which industry sector does Aurinia Pharmaceuticals operate in?
Aurinia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
